July 10, 2019
Life Science Institute President Seiichi Kiso Life Science Institute, a Mitsubishi Chemical Group company, said on July 9 that it has launched a clinical trial in Japan for its multi-lineage differentiating stress enduring (Muse) cell therapy CL2020 to treat patients...read more